Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Practice Life Sciences & Pharma
Organization & Performance Published Articles Workers’ desire to work from home grows as lockdown continues May 22, 2020 New survey shows even more people than in April (now 60%) want to commute less after the COVID crisis, as new working practices become normal.
Life Sciences & Pharma Published Articles After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid… June 17, 2020 After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth.
Life Sciences & Pharma Presentations China Hospital Priorities — Strategic Themes and Implications for Medtechs September 18, 2020 L.E.K., in collaboration with APACMed, conducted a survey with ~400 hospital executives across both public and private hospitals in key APAC markets.
Life Sciences & Pharma Executive Insights CAR-T: Unlocking Barriers to Adoption in Europe June 23, 2020 L.E.K. Consulting reviews progress to date, outlines barriers to uptake and identifies potential catalysts for accelerating European CAR-T adoption.
Healthcare Services Special Report Changing the Future of Chilean Women October 26, 2020 In 2018, almost 2.1 million women were diagnosed with breast cancer, and more than 630,000 female patients died from it.
Digital Healthcare Published Articles Will AI Disrupt the Hospital Industry? September 10, 2020 Artificial intelligence (AI) is poised to disrupt the hospital industry, according to a new report from global management consulting firm L.E.K…
